'Fda overview' presentation slideshows

Romiplostim FDA Overview

Romiplostim FDA Overview. Oncologic Drugs Advisory Committee Meeting Faranak Jamali, MD March 12, 2008. FDA Overview. Chronic ITP efficacy and safety Faranak Jamali, MD Exploratory study in MDS Steven Lemery, MD Risk management considerations Suzanne Berkman, PharmD.

393 views • 26 slides

2.05k views • 10 slides

FDA Overview of Antibiotic Regulatory Activities

176 views • 0 slides